Breaking News:

Abivax announces the pricing of its oversubscribed capital increase of EUR 60M and convertible bonds of EUR 25M, totaling EUR 85M new financing. Learn more at

Share Profile

Abivax SA has been listed on the Paris Stock Exchange since 26 June 2015.

  • ISIN code: FR0012333284
  • Symbol: ABVX
  • ICB Classification: Healthcare 4000/ Biotechnology 4573
  • Market: Euronext Paris-Compartment B
  • Type of Listing: continuous
  • Number of shares: 16,692,268 as of July 30, 2021
  • Indices: CAC ALL SHARES, CAC All-Tradable, CAC MID&SMALL, CAC SMALL, CAC Health Care, CAC Pharma & Bio, and Next Biotech
  • Eligible to French PEA PME


Oddo BHF:

Martial Descoutures

LifeSci Capital | Alpha Series:

Adam Evertts

Bryan, Garnier & Co:

Eric Le Berrigaud & Jean-Jacques Le Fur

goetzpartners securities:

Chris Redhead

Degroof Petercam:

David Seynnaeve

Kepler Cheuvreux:

Damien Choplain


Christophe Dombu

Investor Contact

Chris Maggos LifeSci Advisors +41 79 367 6254